Updated:
BB Biotech
BB Biotech is a listed investment company with permanent capital that invests in biotechnology companies developing and commercializing breakthrough drugs for...
Overview
BB Biotech is a listed investment company with permanent capital that invests in biotechnology companies developing and commercializing breakthrough drugs for significant unmet medical needs. For more than 30 years it has pursued long-term, conviction-driven investment in innovative biotechnology companies, combining deep sector expertise with a disciplined investment approach. It provides focused access to biotech innovation with active portfolio and risk management.
General information
Firm type
Private Equity
Year founded
1993
Location
Region
Europe
Country
Switzerland
City
Schaffhausen
Corporate office
Schaffhausen, Switzerland
Principals
Dr. Thomas von Planta
Präsident des Verwaltungsrats
Prof. Dr. Mads Krogsgaard Thomsen
Vizepräsident des Verwaltungsrats
Laura Hamill
Mitglied des Verwaltungsrats
Dr. Pearl Huang
Mitglied des Verwaltungsrats
Camilla Soenderby
Mitglied des Verwaltungsrats
Dr. Christian Koch
Head BB Biotech Team
Dr. Kyle Rasbach
Head Research
Dr. Jordan Baumhardt
Investment Analyst
Dr. Anna Guinot Aguado
Investment Analyst
Alex Arfaei
Investment Analyst
Sébastien Pires
Head AI BB Biotech
Dr. Olivia Woolley
AI Scientist
Dr. Can Buldun-Gora
AI Engineer
Xinya Guo
Portfolio & Trading Strategist
Frequently asked questions
Does BB Biotech participate in fund commitments or only direct deals?
The strategy description lists early-stage through growth venture activity without specifying fund or direct structure.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: